Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)

Estimated Value: $500,000
Open Healthcaregrant
Mar 11, 2026
Healthcare
grant
AI Summary
This grant opportunity, PAR-26-129, focuses on systematic testing of radionuclides in preclinical experiments. RP1 clinical trials are not allowed under this funding opportunity. The CFDA numbers associated with this opportunity are 93.395 and 93.394.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Radionuclide Testing Services 1 lot $100,000.00 $100,000.00 Medical
Preclinical Experiment Design and Execution 1 lot $150,000.00 $150,000.00 Medical
Data Analysis and Reporting Services 1 lot $75,000.00 $75,000.00 Professional Services
Quality Control and Assurance 1 lot $50,000.00 $50,000.00 Professional Services
Regulatory Compliance Services 1 lot $25,000.00 $25,000.00 Professional Services
Radionuclides 1 lot $100,000.00 $100,000.00 Medical
Estimated Bid Value$500,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids